Blue Owl Capital Co. (NYSE: OBDC) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $17.00 price target on the stock.
Medical Technology Company Secures $35 Million in Equipment Financing From Wingspire Equipment Finance
Blue Owl Capital Corporation Reports Third Quarter Net Investment Income Per Share of $0.47 and Net Asset Value Per Share of $15.28
Blue Owl Capital Co. (NYSE: OBDC) had its price target raised by analysts at Wells Fargo & Company from $14.00 to $14.50. They now have an "underweight" rating on the stock.
Blue Owl Capital Corporation Celebrates the Five-Year Anniversary of Wingspire Capital